-
Mashup Score: 0Home - 12 hour(s) ago
Activity Overview
Source: na.eventscloud.comCategories: General Medicine News, DermatologyTweet
-
Mashup Score: 1Gene Therapies for Hemophilia A and Hemophilia B at #ASH24 - 1 day(s) ago
Explore groundbreaking gene therapies for Hemophilia A and B at #ASH24. Join leading experts for insights into the latest advancements, treatment strategies, and research updates in gene therapy. Stay at the forefront of hemophilia care with cutting-edge discussions and developments.
Source: events.medscapelive.orgCategories: General Medicine News, DermatologyTweet-
🧬 Uncover the latest on gene therapies for hemophilia at #ASH24! 🩺 Get insights into clinical differences, refine patient monitoring, and confidently guide treatment decisions. 🔍 Discover more: https://t.co/RFDHgjgN0Q https://t.co/4SPddanuWZ
-
-
Mashup Score: 0Home - 2 day(s) ago
Activity Overview
Source: na.eventscloud.comCategories: General Medicine News, DermatologyTweet-
📚 Gain insights into the natural history of ITP and evaluate dynamic treatment strategies. 🩺 Enhance your skills in accurate diagnosis and patient-centric care planning. 🌟 Stay updated on evolving evidence to transform ITP care. 💪 https://t.co/YpYbd4ODtw #ASH24 https://t.co/EnL7hP1fPE
-
-
Mashup Score: 2Managing Diverse Hematologic Malignancies at #ASH24 - 3 day(s) ago
Join us at #ASH24 for “Managing Diverse Hematologic Malignancies,” where leading experts will discuss the latest treatment strategies and research. Gain insights into innovative approaches for various hematologic cancers and stay updated on key advancements in the field.
Source: na.eventscloud.comCategories: General Medicine News, DermatologyTweet-
📊 Stay updated on the standards of care for hematologic malignancies and enhance your skills in community-based management. 💉 Gain confidence in tailoring patient-centric treatment plans for optimal outcomes. https://t.co/GyrITa2TkL #Hematology #PatientCare #Oncology #ASH24 https://t.co/e8jMCIIuoC
-
-
Mashup Score: 0Home - 4 day(s) ago
Activity Overview
Source: na.eventscloud.comCategories: General Medicine News, DermatologyTweet-
🧬 Dive into the latest trial data on novel mHSPC treatments. 🔍 Enhance your skills in patient management and 🤝 teamwork to identify those who can benefit from emerging therapies. 🌟 Discover more: https://t.co/sxYK1JUDHm #mHSPC #OncologyInnovation https://t.co/TrYcdKoq22
-
-
Mashup Score: 0Home - 5 day(s) ago
Activity Overview
Source: na.eventscloud.comCategories: General Medicine News, DermatologyTweet-
🔍 Discover the natural history and evolving treatments for AL amyloidosis. 📈 Boost your competence in patient classification and care planning. 💡 Stay updated with crucial evidence to enhance multidisciplinary care. Click here now: https://t.co/p67b47FQnr #ASH24 https://t.co/FjB3JM2c8H
-
-
Mashup Score: 0Home - 5 day(s) ago
Activity Overview
Source: events.medscapelive.orgCategories: General Medicine News, DermatologyTweet-
🔬 THIS WEEK! Explore the latest clinical data on therapies targeting IDH mutations in gliomas. 💡 Build confidence in identifying patients & integrating novel treatments within your multidisciplinary team. 👉 Register now: https://t.co/Sv7ayQ9Rux #Glioma #TargetedTherapies https://t.co/BEbIvIGxj6
-
-
Mashup Score: 0Home - 6 day(s) ago
Activity Overview
Source: na.eventscloud.comCategories: General Medicine News, DermatologyTweet-
🔬 Explore the latest clinical trial data on emerging therapies for DLBCL at first relapse. 📚 Learn key 🔑 factors affecting CAR T-cell therapy eligibility and enhance your competence in selecting personalized treatments. 📊 Click here now: https://t.co/TytW5mYNdQ #ASH24 https://t.co/f3bbQVonlB
-
-
Mashup Score: 0Home - 6 day(s) ago
Activity Overview
Source: na.eventscloud.comCategories: General Medicine News, DermatologyTweet-
🔍 Explore the MoAs & signaling pathways of JAK inhibitors for IBD. 🚨 Understand safety signals and transform clinical data into effective treatment strategies for your patients. 💡 Learn more: https://t.co/8X70euOT1O #IBD #JAKInhibitors https://t.co/H2WreTv2W6
-
-
Mashup Score: 0Home - 6 day(s) ago
Wednesday, November 20, 2024 2:30 PM – 3:00 PM EST CME Virtual Join us for a livestream virtual webinar exploring the intricacies in care for patients with unresectable hepatocellular carcinoma (HCC). This 30-minute event will feature Drs. Lipika Goyal and Tim Greten who will discuss strategies for utilizing first-line immunotherapy in advanced unresectable HCC and highlight considerations in treatment selection and evidence-based management. Participants will have the opportunity to engage with faculty
Source: events.medscapelive.orgCategories: General Medicine News, DermatologyTweet-
📚 Boost your knowledge on immunotherapy for frontline treatment of advanced unresectable HCC. 💡 Gain confidence in choosing the right strategies & understanding combo benefits. 🔗 Learn more: https://t.co/oWRz8avbSV https://t.co/AQE4RvN5u4
-
📌 Understand key risk factors and recognize the symptoms of PTSD. Build confidence in identifying patients who may meet the criteria for a PTSD diagnosis and offer them the support they need. 📍 https://t.co/RaMjqXRs14 #PTSDCare https://t.co/Z5NoPuHayi